@[email protected]M to

US [email protected]English • 7 months ago

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

0

cross-posted to:
news

10

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

arstechnica.com

@[email protected]M to

US [email protected]English • 7 months ago

0

cross-posted to:
news

FDA advisors will meet June 4 to discuss and vote on the therapy's effectiveness.

cross-posted from: https://reddthat.com/post/19935197

You must log in or register to comment.

Chat